Sleep and Circadian Mechanisms in Hypertension
NCT05184933
Cardiovascular Diseases, Cardiovascular Risk Factors
Portland, Oregon, United States
View Trial DetailsNCT Number: NCT00848380
This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases. The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia
Looking for future studies?
Notify MeAll sexes
Observational
Research Site, Arbedo, Canton Ticino, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Inclusion visit, 6 to 9 months before inclusion visit and / or 12 to 15 months before inclusion visit
AstraZeneca
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05184933
Cardiovascular Diseases, Cardiovascular Risk Factors
Portland, Oregon, United States
View Trial DetailsNCT03805529
Cardiovascular Diseases, Cardiovascular Health
Milwaukee, Wisconsin, United States
View Trial DetailsNCT00787306
Cardiovascular Diseases, Cardiovascular Risk Factors
Toronto, Ontario, Canada
View Trial DetailsNCT00882336
Behavior, Body Weight
Alland, Austria
View Trial Details